Leap Therapeutics(LPTX) - 2023 Q4 - Annual Results

Exhibit 99.1 Leap Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results Cambridge, MA – March 18, 2024 – Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial results for the fourth quarter and year ended December 31, 2023. Leap Highlights: "As we reflect on the fourth quarter and the achievements of the past year, we are proud of the strides we've made in advancing DKN- 01 and integrating o ...